반응식
[N+:1]([C:4]1[CH:13]=[CH:12][CH:11]=[C:10]2[C:5]=1[CH:6]=[CH:7][C:8](Cl)=[N:9]2)([O-])=O.[CH3:15][C:16]1[O:17][C:18]2[C:24]([NH2:25])=[CH:23][CH:22]=[CH:21][C:19]=2[CH:20]=1.[N:26]1[CH:31]=[CH:30][CH:29]=[C:28]([CH:32]=O)[CH:27]=1>>[CH3:15][C:16]1[O:17][C:18]2[C:24]([NH:25][C:8]3[CH:7]=[CH:6][C:5]4[C:4]([NH:1][CH2:32][C:28]5[CH:27]=[N:26][CH:31]=[CH:30][CH:29]=5)=[CH:13][CH:12]=[CH:11][C:10]=4[N:9]=3)=[CH:23][CH:22]=[CH:21][C:19]=2[CH:20]=1참가 물질
4
실험 절차
The title compound, MS: m/e=381.0 (M+H+), was prepared from 5-nitro-2-chloroquinoline, (2-methyl-1-benzofuran-7-yl)amine and pyridine-3-carbaldehyde as described in example 26.
출처 및 근거
- ORD 기록
- ord-4b5a9deb2f8840eebab3c4a7316d957f
- 출처 데이터셋
- uspto-grants-2010_11
- 특허 번호
- US07825253B2
연결된 노트
불러오는 중…